Sentara Neuroscience Institute

Norfolk, Virginia

Community Hospital Program
5 Active TrialsMedium Practice
12 MS centers statewide · Ranked #2 in Virginia for clinical trials
What kind of place is this?
Part of Major Health SystemComprehensive Care TeamResearch Focused

You are in a regional neurology setting that blends MS care with a broader network of brain and nerve specialists. You may appreciate the multidisciplinary team, individualized planning, and access to related programs like epilepsy, sleep, stroke, and movement disorders.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services4/5
Clinical Trials & Research2/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care1/5

About Sentara Neuroscience Institute

This center combines MS care with a wide neuroscience network, so you can be seen by specialists across many related neurologic services in one system. Its collaboration with Eastern Virginia Medical School also supports ongoing research activity.

Sentara Neuroscience Institute serves people with multiple sclerosis as part of a broader neurology practice in Norfolk, Virginia. You can also find care for other conditions such as demyelinating diseases, headaches, epilepsy, sleep disorders, stroke, and brain tumors. The institute offers neurology consultations, neuropsychology services, and individualized treatment planning through a multidisciplinary team. Its connection to Sentara Norfolk General Hospital and Eastern Virginia Medical School adds to its regional reach and clinical depth.

Sentara Neuroscience Institute in Norfolk brings together neurology and neuropsychology services for people living with multiple sclerosis and other nervous system conditions. You can receive individualized treatment planning within a multispecialty team that includes neurologists, neurosurgeons, neuroradiologists, nutritionists, physical therapists, occupational therapists, and music therapists. The institute is part of Sentara Medical Group and works closely with Sentara Norfolk General Hospital and Eastern Virginia Medical School. Its broader neuroscience network also supports specialty programs in movement disorders, epilepsy, sleep, spine, and stroke care.

Specialized Programs

Brain Tumor Center
Comprehensive Movement Disorders Program
Epilepsy Center
Seizure and Epilepsy Clinic
Music and Medicine Center
Rehabilitation Centers
Sleep Center
Spine Center
Stroke Program

Partnerships & Referral Network

  • Eastern Virginia Medical School (research collaboration)

Services & Treatments

What They Treat
multiple sclerosisdementiamovement disordersheadachesepilepsysleep disordersneuromuscular diseasesstrokebrain tumorsdemyelinating diseases
How They Treat It
neurology consultationsneuropsychology servicesindividualized treatment planningmultispecialty neurological care

Research & Clinical Trials

This center is currently involved in 5 clinical trials — ranked #2 in Virginia for active trials

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
OfatumumabDisease modifying treatment (DMT)
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose

Insurance & Access

Contact
600 Gresham Drive Suite 8600, Norfolk, VA 23507
Insurance & Support

FAQs from Sentara Neuroscience Institute

Contact the center directly for records or communication.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Website